📰 Zai Lab News
Page 29 - Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.
June 30, 2023
First-and-only approved FcRn antagonist for gMG patients by NMPA 68% of anti-AChR antibody positive gMG patients treated with VYVGART were responders on the Myasthenia Gravis Activities of Daily...
June 30, 2023
By Dina Kartit (Reuters) -Chinas National Medical Products Administration (NMPA) has approved Zai Lab Limiteds and Argenx SEs Biologics License ...
June 30, 2023
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
June 29, 2023
AI is currently being used in the NHS to analyse images - such as mammograms - and support radiologists in making decisions, but experts say it could be greatly improved
June 28, 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf ...
June 28, 2023
SHANGHAI, China and CAMBRIDGE, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the National Medical Products Administration (NMPA) in China has
June 28, 2023
SHANGHAI, China and CAMBRIDGE, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the National Medical Products Administration (NMPA) in China has accepted the New Drug Application (NDA) for repotrec...
June 26, 2023
WHY: NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of
June 26, 2023
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zai Lab Limited (Zai Lab Limited), Hayward
June 24, 2023
NEW YORK , June 23, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited (